Literature DB >> 30918110

Prevention of cystic fibrosis: The beginning of the end?

Thomas W Ferkol1.   

Abstract

Prenatal and postnatal treatment with a CFTR modifier attenuates pathological changes in a ferret model of cystic fibrosis (Sun et al., this issue).
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30918110     DOI: 10.1126/scitranslmed.aax2361

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  3 in total

1.  Rates of adverse and serious adverse events in children with cystic fibrosis.

Authors:  Jessica E Pittman; Umer Khan; Theresa A Laguna; Sonya Heltshe; Christopher H Goss; Don B Sanders
Journal:  J Cyst Fibros       Date:  2021-03-18       Impact factor: 5.482

2.  Preclinical Modeling for Therapeutic Development in Cystic Fibrosis.

Authors:  Tracey L Bonfield
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 3.  Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable.

Authors:  Andrea M Coverstone; Thomas W Ferkol
Journal:  Front Pediatr       Date:  2021-01-11       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.